Posted on 5/13/20
Coty Sells Off Its Wella Beauty and Hair Care Brands for Over $4 Billion
Beauty, personal care, and cosmetics company Coty (NYSE:COTY) is spinning off its Wella division into a standalone company as part of a $4.3 billion investment deal . . .
Posted on 5/12/20
VirtualHealth Partners with Change Healthcare
NEW YORK--(BUSINESS WIRE)--VirtualHealth, provider of HELIOS, the leading SaaS care management platform, today announced a certified integration with Change Healthcare’s InterQual Connect™ to reduce the administrative . . .
Posted on 5/12/20
Yale New Haven Health Partners with Capsule Technologies
Yale New Haven Health System (YNHHS), the largest health system in Connecticut, has deployed Capsule's Ventilated Patient Surveillance (VPS) workstation to deliver safe and effective patient . . .
Posted on 5/12/20
Medical Device Maker Ambu Launches New Single-Use Cystoscope for Improved Workflow and Enhanced Productivity Benefits
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, introduced today a new single-use cystoscope. The Ambu® aScope™ 4 Cysto will . . .
Posted on 5/12/20
DarioHealth Reports First Quarter 2020 Results
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and . . .
Posted on 5/12/20
States with the Most Vulnerable Populations to Coronavirus – WalletHub Study
With nearly 75 percent of patients hospitalized for coronavirus being at least 50 years old, and around 90 percent having pre-existing conditions, it’s important for states . . .
Posted on 5/12/20
Bristol Myers Squibb Offers bluebird bio a $200 Million Royalty Buyout
A couple of complex collaboration agreements that Bristol Myers Squibb (NYSE:BMY) inherited from Celgene are about to get a lot simpler. The big pharma is going . . .
Posted on 5/12/20
Why Intercept Pharmaceuticals Stock Caught Fire in April
What happenedIntercept Pharmaceuticals (NASDAQ:ICPT), a mid-cap liver disease specialist, saw its shares rise by a healthy 40.3% over the course of April, according to data from . . .
Posted on 5/12/20
Why Teladoc Stock Jumped Today
What happenedShares of Teladoc Health (NYSE:TDOC) leapt 8% on Monday, furthering the healthcare technology stock's torrid gains so far this year.So whatSeveral factors likely contributed to . . .
Posted on 5/11/20
Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical Agreements with bluebird bio
ALLENDALE, N.J. & MUNICH--(BUSINESS WIRE)--Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS) and apceth Biopharma GmbH (apceth), both subsidiaries of Hitachi Chemical Co., Ltd. (Hitachi Chemical) today . . .
Posted on 5/11/20
Quest Diagnostics Prices $550M of Senior Notes
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $550 million aggregate principal . . .
Posted on 5/11/20
Olvad Holdings Announces Strategic Partnership with Obtain Medical
As a result of the Global Pandemic of Covid-19, Obtain Medical (the sister company of the internationally respected Solve Distribution) has partnered with Olvad Holdings to . . .
Posted on 5/11/20
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus today announced a large-scale research . . .
Posted on 5/11/20
Eagle Pharmaceuticals Reports First Quarter 2020 Results
WOODCLIFF LAKE, N.J--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced financial results for the three months ended March 31, 2020.Business and Recent Highlights: Despite the ongoing . . .
Posted on 5/11/20
Amneal Reports First Quarter 2020 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the first quarter ended March 31, 2020.“We are proud of how Amneal has responded to . . .
Posted on 5/11/20
Applied Therapeutics Reports First Quarter 2020 Financial Results
NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 5/11/20
Oyster Point Pharma Reports First Quarter 2020 Financial Results and Recent Business Highlights
PRINCETON, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of . . .
Posted on 5/11/20
Bristol-Myers Squibb: This Could Be The Next Quarter Trillion Dollar Company
SummaryBristol-Myers Squibb has actually seen improved performance as a result of COVID-19. That's perfect as the company is paying off a big acquisition.BMY has a market . . .
Posted on 5/11/20
Quest Diagnostics’ History of Acquisitions is Paying Off
Quest Diagnostics (NYSE:DGX) is a resilient healthcare company, even in the face of its recent furloughs, layoffs, and pay cuts prompted by the COVID-19 pandemic.Boasting revenues . . .
Posted on 5/11/20
Better Coronavirus Stock: Quest Diagnostics or LabCorp?
It could take a while before there's a safe and effective vaccine for COVID-19. Antiviral drugs could help in treating the novel coronavirus disease but they . . .
Posted on 5/11/20
Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine
Pfizer (NYSE:PFE) is taking on significant risk in a race to provide the world with a coronavirus vaccine. Pfizer is outsourcing the production of its own . . .
Posted on 5/11/20
Better Coronavirus Stock: Inovio Pharmaceuticals or Regeneron?
One welcome sign with the COVID-19 pandemic is how many companies, both large and small, have scrambled to develop diagnostic tests, antiviral treatments, and vaccines. Sure, . . .
Posted on 5/11/20
Is Axsome Therapeutics a Screaming Buy?
The past few weeks have been quite busy for Axsome Therapeutics (NASDAQ:AXSM), notching two wins and one failure in late-stage clinical trials.On March 30, the company . . .
Posted on 5/10/20
Emerald Organic Products Restructures Joint Venture Agreement with Todos Medical
HOLBROOK, NY, REHOVOT, ISRAEL, SINGAPORE AND NEW YORK, NY, May 08, 2020 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC: EMOR) ("Emerald") a diversified health sciences . . .
Posted on 5/10/20
Caladrius Biosciences Provides Corporate Update
BASKING RIDGE, N.J. , May 07, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies . . .
New York
